5 insiders reported 16 Form 4 transactions for PharmaCyte Biotech, Inc. (PMCB) over the past 18 months (most recent 2026-01-07). Recent activity: Silverman Joshua (CEO and President) Buy 30,000 shares, Silverman Joshua (CEO and President) Buy 30,000 shares, Silverman Joshua (CEO and President) Buy 40,000 shares, SCHECHTER JONATHAN (Director) Buy 20,000 shares, SCHECHTER JONATHAN (Director) Buy 20,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-07 | Silverman Joshua | CEO and President | Buy | 30,000 | $23,400 |
| 2026-01-07 | Silverman Joshua | CEO and President | Buy | 30,000 | $23,700 |
| 2026-01-07 | Silverman Joshua | CEO and President | Buy | 40,000 | $33,200 |
| 2026-01-07 | SCHECHTER JONATHAN | Director | Buy | 20,000 | $15,600 |
| 2026-01-07 | SCHECHTER JONATHAN | Director | Buy | 20,000 | $15,800 |
| 2026-01-07 | SCHECHTER JONATHAN | Director | Buy | 20,000 | $16,800 |
| 2025-12-12 | Silverman Joshua | CEO and President | Buy | 575,000 | $0 |
| 2025-12-12 | Silverman Joshua | CEO and President | Sell | 258,750 | $263,925 |
| 2025-12-12 | WEINSTEIN ROBERT | Director | Buy | 75,000 | $0 |
| 2025-12-12 | WEINSTEIN ROBERT | Director | Sell | 33,750 | $34,425 |
| 2025-12-12 | WALKER WAYNE REMELL | Director | Buy | 37,500 | $0 |
| 2025-12-12 | WALKER WAYNE REMELL | Director | Sell | 16,875 | $17,212 |
| 2025-12-12 | SCHECHTER JONATHAN | Director | Buy | 150,000 | $0 |
| 2025-12-12 | SCHECHTER JONATHAN | Director | Sell | 67,500 | $68,850 |
| 2025-12-12 | Abecassis Michael M | Director | Buy | 37,500 | $0 |
| 2025-12-12 | Abecassis Michael M | Director | Sell | 16,875 | $17,212 |
Source: SEC Form 4 filings · as of 2026-01-07